Key facts
- Carrie S. Cox has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $19,301,371.
- Recent insider filing activity is available below.
Reporting Owner Activity for Carrie S. Cox
- Location
- Kenilworth, NJ
- Ownership summary
-
The estimated value of Carrie S. Cox's disclosed insider holdings is at least $19,301,371 as of 18 May 2026.
- Director: TEXAS INSTRUMENTS INC (TXN) reported at about $11.55M
- Director: CARDINAL HEALTH INC (CAH) reported at about $4.46M
- Director: Solventum Corp (SOLV) reported at about $1.89M
- Executive Chair, Director: Organon & Co. (OGN) reported at about $1.34M
- Director: Cartesian Therapeutics, Inc. (RNAC) reported at about $57.9K
Values are based on parsed SEC Forms 3/4/5 and should be verified against the source filing.
- Signature
- /s/Megan Bombick, attorney-in-fact for Carrie S. Cox
- Source filings
- Open source filing history
Follow Filing Activity
Follow Carrie S. Cox and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Change
- Largest disclosed position: TEXAS INSTRUMENTS INC ($11,552,811).
- Past-year value change for that position: -$2,708,029.
Research use
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Reported issuer positions for Carrie S. Cox
TXN
Forms 3/4/5
TEXAS INSTRUMENTS INC
- Relationship
- Director
- Holdings value
- $11,552,811
- Past year net change
- -$2,708,029
- Change %
- -19%
- Report period
- 13 May 2026
CAH
Forms 3/4/5
CARDINAL HEALTH INC
- Relationship
- Director
- Holdings value
- $4,457,847
- Past year net change
- Change %
- Report period
- 09 Nov 2022
SOLV
Forms 3/4/5
Solventum Corp
- Relationship
- Director
- Holdings value
- $1,892,141
- Past year net change
- Change %
- Report period
- 15 May 2026
OGN
Forms 3/4/5
Organon & Co.
- Relationship
- Executive Chair, Director
- Holdings value
- $1,340,676
- Past year net change
- +$501,755
- Change %
- +60%
- Report period
- 12 Nov 2025
RNAC
Forms 3/4/5
Cartesian Therapeutics, Inc.
- Relationship
- Director
- Holdings value
- $57,896
- Past year net change
- Change %
- Report period
- 02 Jan 2025
Insider Transactions Reported by Carrie S. Cox:
| Sym | Company | Class | Transaction | % | Reported value | Reported price | Shares | Shares after | Date | Ownership |
|---|
An asterisk next to the price means the reported price is likely invalid.